Gut hormones and gut microbiota: implications for kidney function and hypertension
- PMID: 27865823
- DOI: 10.1016/j.jash.2016.10.007
Gut hormones and gut microbiota: implications for kidney function and hypertension
Abstract
Increased blood pressure (BP) and chronic kidney disease are two leading risk factors for cardiovascular disease. Increased sodium intake is one of the most important risk factors for development of hypertension. Recent data have shown that gut influences kidney function and BP by variety of mechanisms. Various hormones and peptides secreted from gut such as gastrin, glucocorticoids, Glucagon-like peptide-1 impact on kidney function and BP especially influencing sodium absorption from gut. These findings stimulate scientist to find new therapeutic options such as tenapanor for treatment of hypertension by blocking sodium absorption from gut. The gastrointestinal tract is also occupied by a huge community of microbes (microbiome) that under normal condition has a symbiotic relationship with the host. Alterations in the structure and function of the gut microbiota have been shown to play a key role in the pathogenesis and complications of numerous diseases including hypertension. Based on these data, in this review, we provide a summary of the available data on the role of gut and gut microbiota in regulation of BP and kidney function.
Keywords: Intestinal hormones; Na+/H+ exchanger-3; kidney disease; microbiota.
Copyright © 2016 American Society of Hypertension. All rights reserved.
Similar articles
-
Hypertension as a Metabolic Disorder and the Novel Role of the Gut.Curr Hypertens Rep. 2019 Jun 24;21(8):63. doi: 10.1007/s11906-019-0964-5. Curr Hypertens Rep. 2019. PMID: 31236708 Free PMC article. Review.
-
Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans.Sci Transl Med. 2014 Mar 12;6(227):227ra36. doi: 10.1126/scitranslmed.3007790. Sci Transl Med. 2014. PMID: 24622516 Clinical Trial.
-
Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management.Curr Opin Nephrol Hypertens. 2015 Sep;24(5):410-6. doi: 10.1097/MNH.0000000000000154. Curr Opin Nephrol Hypertens. 2015. PMID: 26197202 Review.
-
Sodium, hypertension, and the gut: does the gut microbiota go salty?Am J Physiol Heart Circ Physiol. 2019 Dec 1;317(6):H1173-H1182. doi: 10.1152/ajpheart.00312.2019. Epub 2019 Oct 4. Am J Physiol Heart Circ Physiol. 2019. PMID: 31585045 Free PMC article. Review.
-
Alterations of intestinal barrier and microbiota in chronic kidney disease.Nephrol Dial Transplant. 2015 Jun;30(6):924-33. doi: 10.1093/ndt/gfu287. Epub 2014 Sep 4. Nephrol Dial Transplant. 2015. PMID: 25190600 Review.
Cited by
-
Sodium Homeostasis, a Balance Necessary for Life.Nutrients. 2023 Jan 12;15(2):395. doi: 10.3390/nu15020395. Nutrients. 2023. PMID: 36678265 Free PMC article. Review.
-
Obesity, kidney dysfunction, and inflammation: interactions in hypertension.Cardiovasc Res. 2021 Jul 7;117(8):1859-1876. doi: 10.1093/cvr/cvaa336. Cardiovasc Res. 2021. PMID: 33258945 Free PMC article. Review.
-
Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease.Diseases. 2019 Feb 13;7(1):21. doi: 10.3390/diseases7010021. Diseases. 2019. PMID: 30781823 Free PMC article. Review.
-
Hypertension and cellular senescence.Biogerontology. 2023 Aug;24(4):457-478. doi: 10.1007/s10522-023-10031-4. Epub 2023 Apr 3. Biogerontology. 2023. PMID: 37010665 Review.
-
The potential impact of a probiotic: Akkermansia muciniphila in the regulation of blood pressure-the current facts and evidence.J Transl Med. 2022 Sep 24;20(1):430. doi: 10.1186/s12967-022-03631-0. J Transl Med. 2022. PMID: 36153618 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical